Osiris Therapeutics (OSIR) Gains Following Positive Outcome from Grafix Post-Market Clinical Trial
Tweet Send to a Friend
Osiris Therapeutics, Inc. (NASDAQ: OSIR) is gains 8% after-hours after the company announced today that the manuscript from its multicenter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
